Einträge von Sabel, Michael auf dem Publikationsserver

Weller, Johannes , Schäfer, Niklas, Schaub, Christina, Potthoff, Anna-Laura, Steinbach, Joachim P., Schlegel, Uwe, Sabel, Michael , Hau, Peter , Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Pietsch, Torsten, Tzaridis, Theophilos, Zeyen, Thomas, Borger, Valeri, Güresir, Erdem, Vatter, Hartmut, Herrlinger, Ulrich und Schneider, Matthias (2022) Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS. Journal of Neuro-Oncology 159 (1), S. 95-101.

Zeyen, Thomas, Potthoff, Anna-Laura, Nemeth, Robert, Heiland, Dieter H., Burger, Michael C., Steinbach, Joachim P., Hau, Peter, Tabatabai, Ghazaleh, Glas, Martin, Schlegel, Uwe, Grauer, Oliver, Krex, Dietmar, Schnell, Oliver, Goldbrunner, Roland, Sabel, Michael , Thon, Niklas, Delev, Daniel, Clusmann, Hans, Seidel, Clemens, Güresir, Erdem, Schmid, Matthias , Schuss, Patrick , Giordano, Frank A., Radbruch, Alexander, Becker, Albert, Weller, Johannes, Schaub, Christina, Vatter, Hartmut, Schilling, Judith, Winkler, Frank , Herrlinger, Ulrich und Schneider, Matthias (2022) Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial. Trials 23 (1). Volltext nicht vorhanden.

Kamp, Marcel A., Malzkorn, Bastian, von Sass, Christiane, DiMeco, Francesco, Hadjipanayis, Constantinos G., Senft, Christian , Rapp, Marion, Gepfner-Tuma, Irina, Fountas, Konstantinos, Krieg, Sandro M. , Neukirchen, Martin, Florian, Ioan Ștefan, Schnell, Oliver, Mijderwijk, Hendrik-Jan , Perin, Alessandro , Baumgarten, Peter, van Lieshout, Jasper H., Thon, Niklas, Renovanz, Miriam, Kahlert, Ulf, Spoor, Jochem K. H., Hänggi, Daniel, McLean, Aaron Lawson, Mäurer, Matthias, Sarrubbo, Silvio, Freyschlag, Christian F. , Schmidt, Nils O. , Vergani, Francesco, Jungk, Christine, Stein, Marco, Forster, Marie-Therese, Weinberg, Jeffrey S. , Sinclair, John, Belykh, Evgenii, Bello, Lorenzo , Mandonnet, Emmanuel, Moiyadi, Aliasgar und Sabel, Michael (2021) Proposed definition of competencies for surgical neuro-oncology training. Journal of Neuro-Oncology 153 (1), S. 121-131.

Tzaridis, Theophilos , Schäfer, Niklas, Weller, Johannes, Steinbach, Joachim‐Peter, Schlegel, Uwe, Seidel, Sabine, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Tonn, Jörg‐Christian, Grauer, Oliver, Kebir, Sied, Schneider, Matthias, Schaub, Christina, Vatter, Hartmut, Coch, Christoph, Glas, Martin, Fimmers, Rolf, Pietsch, Torsten, Reifenberger, Guido, Herrlinger, Ulrich und Felsberg, Jörg (2021) MGMT promoter methylation analysis for allocating combined CCNU / TMZ chemotherapy: Lessons learned from the CeTeG / NOA ‐09 trial. International Journal of Cancer 148 (7), S. 1695-1707. Volltext nicht vorhanden.

Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke , Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert , Weller, Johannes , Mack, Frederic, Tzaridis, Theophilos, Bähr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh , Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin und Herrlinger, Ulrich (2019) Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial. Journal of Neuro-Oncology 144 (3), S. 501-509. Volltext nicht vorhanden.

Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter , Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh , Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert , Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes , Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang , Weller, Michael , Fimmers, Rolf, Schmid, Matthias , Hattingen, Elke , Pietsch, Torsten, Coch, Christoph und Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial. The Lancet 393 (10172), S. 678-688. Volltext nicht vorhanden.

Schaub, Christina, Kebir, Sied, Junold, Nina, Hattingen, Elke , Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter , Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Bähr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich und Glas, Martin (2018) Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. Journal of Cancer Research and Clinical Oncology 144 (8), S. 1581-1589. Volltext nicht vorhanden.

Schäfer, Niklas, Proescholdt, Martin, Steinbach, Joachim P, Weyerbrock, Astrid, Hau, Peter , Grauer, Oliver, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W, Uhl, Martin, Grau, Stefan, Hänel, Mathias, Schnell, Oliver, Krex, Dietmar, Vajkoczy, Peter, Tabatabai, Ghazaleh, Mack, Frederic, Schaub, Christina, Tzaridis, Theophilos, Nießen, Michael, Kebir, Sied, Leutgeb, Barbara, Urbach, Horst, Belka, Claus, Stummer, Walter, Glas, Martin und Herrlinger, Ulrich (2017) Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro-Oncology 20 (7), S. 975-985. Volltext nicht vorhanden.

Herrlinger, Ulrich, Schäfer, Niklas, Steinbach, Joachim P. , Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W. , Uhl, Martin, Maciaczyk, Jaroslaw, Grau, Stefan, Schnell, Oliver, Hänel, Mathias, Krex, Dietmar, Vajkoczy, Peter, Gerlach, Rüdiger, Kortmann, Rolf-Dieter, Mehdorn, Maximilian, Tüttenberg, Jochen, Mayer-Steinacker, Regine, Fietkau, Rainer, Brehmer, Stefanie, Mack, Frederic, Stuplich, Moritz, Kebir, Sied, Kohnen, Ralf, Dunkl, Elmar, Leutgeb, Barbara, Proescholdt, Martin, Pietsch, Torsten, Urbach, Horst, Belka, Claus, Stummer, Walter und Glas, Martin (2016) Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. Journal of Clinical Oncology 34 (14), S. 1611-1619. Volltext nicht vorhanden.

Galldiks, Norbert , Dunkl, Veronika, Stoffels, Gabriele , Hutterer, Markus, Rapp, Marion, Sabel, Michael, Reifenberger, Guido, Kebir, Sied, Dorn, Franziska, Blau, Tobias, Herrlinger, Ulrich, Hau, Peter, Ruge, Maximilian I., Kocher, Martin, Goldbrunner, Roland, Fink, Gereon R. , Drzezga, Alexander, Schmidt, Matthias und Langen, Karl-Josef (2015) Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET. European Journal of Nuclear Medicine and Molecular Imaging 42 (5), S. 685-695. Volltext nicht vorhanden.

Suchorska, Bogdana, Weller, Michael, Tabatabai, Ghazaleh, Senft, Christian , Hau, Peter, Sabel, Michael, Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe S., Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Joerg und Wirsching, Hans-Georg (2015) Does extent of resection matter in recurrent glioblastoma? Lessons from the DIRECTOR trial. Journal of Clinical Oncology 33 (15_sup), S. 2041. Volltext nicht vorhanden.

Wick, Wolfgang, Platten, Michael, Meisner, Christoph, Felsberg, Jörg, Tabatabai, Ghazaleh, Simon, Matthias, Nikkhah, Guido, Papsdorf, Kirsten, Steinbach, Joachim P., Sabel, Michael, Combs, Stephanie E., Vesper, Jan, Braun, Christian, Meixensberger, Jürgen, Ketter, Ralf, Mayer-Steinacker, Regine, Reifenberger, Guido und Weller, Michael (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. The lancet oncology 13 (7), S. 707-715. Volltext nicht vorhanden.

Floeth, Frank W., Pauleit, Dirk, Sabel, Michael, Stoffels, Gabriele, Reifenberger, Guido, Riemenschneider, Markus J., Jansen, Paul, Coenen, Heinz H., Steiger, Hans-Jakob und Langen, Karl-Josef (2007) Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma. Journal of nuclear medicine : official publication 48 (4), S. 519-527. Volltext nicht vorhanden.